Shilajit: Testosterone, Strength, Human Trials, and Heavy-Metal Safety

Bottom line: Shilajit has a few randomized human studies that are genuinely interesting, including testosterone and muscular-fatigue outcomes. The bigger problem is generalization: Shilajit is a chemically variable natural material, so results from one purified product cannot be assigned to every resin or capsule sold under the name.

The testosterone trial

A randomized double-blind placebo-controlled study enrolled healthy men aged 45 to 55 and tested purified Shilajit for 90 days.[1]

The active group showed higher total testosterone, free testosterone, and DHEAS compared with placebo.

That is a direct human hormonal result.

It does not establish that Shilajit raises testosterone in younger men, men with diagnosed hypogonadism, women, or every commercial product.

The strength study

A separate randomized study enrolled 63 recreationally active young men and tested two doses of Shilajit against placebo for eight weeks.[2]

The higher-dose group showed a smaller fatigue-related decline in maximal isometric strength under the study protocol.

That is a useful performance signal, but it is not the same as demonstrating larger muscle gain, higher one-repetition maximum strength, or better athletic performance across sports.

Product identity is unusually important

Shilajit is a complex natural material containing humic substances, minerals, and many other constituents.

Geography and processing can materially change composition.

That means a trial on a purified standardized product is not a trial on random raw resin purchased online.

Heavy-metal findings are mixed—and that is the point

A 2024 review documented that Shilajit can contain multiple metals, including toxic elements, with some reports exceeding permissible levels.[3]

A newer 2026 analytical study of 12 samples found substantial geographic variability but reported toxic metals below the thresholds used by that study.[4]

These findings are not actually contradictory. They show product variability.

Safety depends on source, purification, testing, and batch quality.

"Contains fulvic acid" is not enough

Commercial Shilajit products are often marketed around fulvic-acid percentage.

That does not tell the entire composition, prove purity, or substitute for contaminant testing.

A chemically complex geologic-biological material needs stronger quality control than a single isolated molecule.

What would make the human results easier to generalize?

Replication should start with product identity. A future trial should report the source material, purification process, relevant chemical characterization, contaminant testing, dose, and batch consistency. Without those details, a positive result may be real for the studied preparation while remaining difficult to apply to the wider Shilajit market.

The testosterone finding also needs population-specific replication. A change in healthy middle-aged men does not establish the same hormonal response in younger adults, people with clinically low testosterone, women, or athletes. The strength-fatigue result is similarly narrow: it measures a particular response under a particular protocol rather than proving greater muscle growth or sport performance.

Safety evidence should travel with efficacy evidence. Because composition varies, a clean result from one purified batch cannot serve as a contaminant guarantee for unrelated products. That makes third-party analytical quality a separate evidence question, not a footnote to the clinical trials.

Verdict

Shilajit has preliminary human evidence for a few outcomes, including testosterone and fatigue-related strength.

Its biggest evidence lesson is that the studied preparation matters enormously. Human-trial findings and product-quality testing need to stay connected on the same page.